Faced with many regulatory bottlenecks, the European cell therapy community must unite and confront these challenges head-on. The 3rd Cell Therapy Analytical Development Summit Europe is your unmissable opportunity to connect with peers, share pain points and establish analytical standards for smoother interactions with regulatory bodies including the FDA, EMA and MHRA.

Join analytical development and quality control experts from industry-leaders like Achilles Therapeutics, Avobis Bio, Bristol Myers Squibb, Johnson and Johnson, GSK, MHRA, to tackle challenges from product characterisation to method validation and release preparation.

Seize the chance this September to collaborate, connect and share insights to drive the future development of potent, safe and effective autologous and allogeneic cell therapies forward!

⌛ Event Dates & Venue

03 Sep - 05 Sep 2024, 9:00 am - 4:00 pm
#_REVIEWS

💸 Website & Tickets

Go to Event Website
Ticket Pricing:
Conference + 2 Workshops - Drug Developer Pricing: GBP 2997.00, Conference + 1 Workshops - Drug Developer Pricing: GBP 2598.00, Conference Only - Drug Developer Pricing: GBP 2199.00, Conference + 2 Workshops - Standard Pricing: GBP 4297.00, Conference + 1 Workshop - Standard Pricing: GBP 3698.00, Conference Only - Standard Pricing: GBP 3099.00, Conference + 2 Workshops - Academic Pricing: GBP 2397.00, Conference + 1 Workshop - Academic Pricing: GBP 2098.00, Conference Only - Academic Pricing: GBP 1799.00

◑ Topics | Categories






Advertisements